Home Authors Posts by staff

staff

62 POSTS 0 COMMENTS

A Global Commission to accelerate diagnosis in rare diseases

Completed the acquisition of Juno Therapeutics

A new partnership to treat Sma

Phase 2a clinical study on Molgradex for the treatment of NTM...

A new kilolab plant to develop and manufacture a wider range...

New phase 2 data for upadacitinib in 52-week Crohn’s disease

Phase 2a clinical study on Molgradex for the treatment of NTM...

Encouraging results for bispecific antibody in macular diabetic edema

First bispecific monoclonal antibody approved to treat hemophilia A with inhibitors

Somatic cell therapy product to treat complex anal fistulas in Crohn’s...

123...7Page 2 of 7

Newsstand

  • NCF International n.2 - 2024
  • Supplemento to n.1 - January 2024 NCF International n.1 - 2024
  • Supplemento al n.8 - Ottobre 2023 NCF International 2023
Newsstand
© © 2024 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151